Qulipta 60 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FHY3S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,879
Award facts
- Contract value 100% obligated
- $54,878.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $54,878.67 to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count packages) on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a critical position in the federal medical supply chain through its comprehensive IDC vehicle that enables the delivery of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order exemplifies the company's role in fulfilling specialized pharmaceutical procurement requirements for the Defense Health Agency and other federal healthcare systems. The SPE2DX contract serves as a flexible mechanism for fulfilling the diverse medical supply needs of U.S. military and veteran healthcare systems across multiple therapeutic domains, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26FHY3S?
SPE2DR26FHY3S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26FHY3S worth?
The government has obligated $54,879 on SPE2DR26FHY3S.
Is contract SPE2DR26FHY3S an order under another contract?
Yes. SPE2DR26FHY3S is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHY3S competed?
The extent of competition for SPE2DR26FHY3S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award